Increased resting lipid oxidation in Crohn's disease

被引:42
|
作者
Mingrone, G [1 ]
Greco, AV [1 ]
Benedetti, G [1 ]
Capristo, E [1 ]
Semeraro, R [1 ]
Zoli, G [1 ]
Gasbarrini, G [1 ]
机构
[1] UNIV CATTOLICA SACRO CUORE,IST CLIN MED,POLICLIN A GEMELLI,CATTEDRA MED INTERNA,I-00168 ROME,ITALY
关键词
Crohn's disease; resting energy expenditure; respiratory quotient; body composition;
D O I
10.1007/BF02208586
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Resting energy expenditure (REE) was measured by indirect calorimetry and body composition was assessed by both direct (bioimpedance) and indirect (anthropometry) methods in 20 hospitalized patients with biopsy-proven ileal Crohn's disease and in a group of 16 healthy volunteers matched for sex, age, and height with the patient group. The Crohn's disease activity index was below 120 in all patients studied, who were treated with a low dose of corticosteroids (0.2-0.3 mg/kg body wt of prednisone). The average weight of Crohn's patients was significantly lower than that of controls (55.70 vs 70.50 kg, P < 0.001) due to both lower fat mass (9.97 vs 18.30 kg, P < 0.001) and lower lean body mass (45.72 vs 52.20 kg, P < 0.02). The average REE was significantly higher in the control group (1785.42 +/- 7.503 vs 1559.1 +/- 48.39 kcal/day, P < 0.001). However, these differences disappeared when REE was normalized by lean body mass (LBM) (34.49 +/- 2.56 vs 34.704 +/- 3.75 kcal/kg LBM P = NS). The nonprotein respiratory quotient was significantly lower in the patient group (0.823 +/- 0.031 vs 0.882 +/- 0.012, P < 0.025), indicating an increased lipid oxidation. This increased lipid oxidation might explain the reduced fat stores found in the group of Crohn's patients, suggesting also that a sufficiently lipid-rich diet could be useful in their nutritional management.
引用
收藏
页码:72 / 76
页数:5
相关论文
共 50 条
  • [1] Increased anal resting pressure and rectal sensitivity in Crohn's disease
    Andersson, P
    Olaison, G
    Hallböök, O
    Boeryd, B
    Sjödahl, R
    DISEASES OF THE COLON & RECTUM, 2003, 46 (12) : 1685 - 1689
  • [2] Lipid redistribution in Crohn's disease
    Luu, Lan Chi T.
    Newcomer, Bradley
    de Villiers, Willem J. S.
    Reid, Michael B.
    Winter, Trevor A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S464 - S464
  • [3] Family History of Crohn's Disease Is Associated with an Increased Risk for Crohn's Disease of the Pouch
    Shen, Bo
    Remzi, Feza H.
    Hammel, Jeffrey P.
    Lashner, Bret A.
    Bevins, Charles L.
    Lavery, Ian C.
    Wehkamp, Jan
    Fazio, Victor W.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (02) : 163 - 170
  • [4] Measles, measles vaccination, and Crohn's disease - Crohn's disease has not increased in Finland
    Pebody, RG
    Paunio, M
    Ruutu, P
    BRITISH MEDICAL JOURNAL, 1998, 316 (7146): : 1745 - 1746
  • [5] Resting energy expenditure in adult patients with Crohn's disease
    Sammarco, Rosa
    Marra, Maurizio
    Pagano, Maria Carmen
    Alfonsi, Lucia
    Santarpia, Lidia
    Cioffi, Iolanda
    Contaldo, Franco
    Pasanisi, Fabrizio
    CLINICAL NUTRITION, 2017, 36 (02) : 467 - 470
  • [6] CHANGE IN DISEASE ACTIVITY AND RESTING ENERGY EXPENDITURE IN CHILDREN WITH CROHN'S DISEASE
    Wiskin, A. E.
    Wootton, S. A.
    Beattie, R. M.
    GUT, 2011, 60 : A100 - A100
  • [7] RESTING ENERGY EXPENDITURE IS NOT ASSOCIATED WITH DISEASE ACTIVITY IN CHILDREN WITH CROHN'S DISEASE
    Wiskin, A. E.
    Wootton, S. A.
    Beattie, R. M.
    GUT, 2011, 60
  • [8] Lipid and Bile Acid Dysmetabolism in Crohn's Disease
    Uchiyama, Koji
    Kishi, Hisashi
    Komatsu, Wataru
    Nagao, Masanori
    Ohhira, Shuji
    Kobashi, Gen
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [9] Increased protein catabolism correlates with increased disease activity in children with Crohn's disease
    Patel, Ashish
    Andersen, John M.
    Hardin, Dana
    GASTROENTEROLOGY, 2006, 130 (04) : A650 - A650
  • [10] Increased bone resorption in patients with Crohn's disease
    Robinson, RJ
    Iqbal, SJ
    Abrams, K
    Al-Azzawi, F
    Mayberry, JF
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 699 - 705